Cargando…

Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications

The development of human benign or malignant prostatic diseases is closely associated with androgens, primarily testosterone (T) and dihydrotestosterone (DHT). T is converted to DHT by 5-alpha reductase (5-AR) isozymes. Differential expression of 5-AR isozymes is observed in both human benign and ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Kai, Fan, Dong-Dong, Jin, Song, Xing, Nian-Zeng, Niu, Yi-Nong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955340/ https://www.ncbi.nlm.nih.gov/pubmed/24457841 http://dx.doi.org/10.4103/1008-682X.123664

Ejemplares similares

The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
por: Azzouni, Faris, et al.
Publicado: (2012)

Bisphenol A Exposure during Adulthood Alters Expression of Aromatase and 5α-Reductase Isozymes in Rat Prostate
por: Castro, Beatriz, et al.
Publicado: (2013)

Bisphenol A Modifies the Regulation Exerted by Testosterone on 5α-Reductase Isozymes in Ventral Prostate of Adult Rats
por: Sánchez, Pilar, et al.
Publicado: (2013)

5-alpha-reductase and the development of the human prostate
por: Radmayr, C., et al.
Publicado: (2008)

Methylated CpG dinucleotides in the 5-α reductase 2 gene may explain finasteride resistance in benign prostatic enlargement patients
por: Lin, Zhe-Min, et al.
Publicado: (2020)

The intriguing role of fibroblasts and c-Jun in the chemopreventive and therapeutic effect of finasteride on xenograft models of prostate cancer
por: Niu, Yi-Nong, et al.
Publicado: (2016)

Role of 5 alpha-reductase inhibitors in the management of prostate cancer
por: Hudak, Steven J, et al.
Publicado: (2006)

Prostate Cancer Mortality and Use of 5-Alpha Reductase Inhibitors
por: Foldes, Cara A., et al.
Publicado: (2020)

5-alpha reductase inhibitors use in prostatic disease and beyond
por: Chislett, Bodie, et al.
Publicado: (2023)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
por: Kim, Eric H., et al.
Publicado: (2018)

5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity
por: Wang, Ziting, et al.
Publicado: (2023)

Clinical Effects of Discontinuing 5-Alpha Reductase Inhibitor in Patients With Benign Prostatic Hyperplasia
por: Kim, Won, et al.
Publicado: (2014)

Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia
por: Cho, Kang Jun, et al.
Publicado: (2011)

Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
por: Azizi, Aziemah, et al.
Publicado: (2021)

Prostate cancer patients can benefit from 5-alpha-reductase inhibitor treatment: a meta-analysis
por: Deng, Tuo, et al.
Publicado: (2020)

Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
por: Youn, Dong-Hyun, et al.
Publicado: (2018)

Corrigendum: Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro
por: Youn, Dong-Hyun, et al.
Publicado: (2019)

Association of 5-alpha-reductase inhibitor and prostate cancer incidence and mortality: a meta-analysis
por: Hu, Xu, et al.
Publicado: (2020)

Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
por: Falagario, Ugo G., et al.
Publicado: (2023)

Androgen Regulation of 5α-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention
por: Li, Jin, et al.
Publicado: (2011)

Differential localization of protein kinase C isozymes in retinal neurons
Publicado: (1991)

Current Status of 5α-Reductase Inhibitors in Prostate Disease Management
por: Kang, Dong Il, et al.
Publicado: (2013)

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia
por: Hagberg, Katrina Wilcox, et al.
Publicado: (2017)

Aconiti Lateralis Radix Preparata, the Dried Root of Aconitum carmichaelii Debx., Improves Benign Prostatic Hyperplasia via Suppressing 5-Alpha Reductase and Inducing Prostate Cell Apoptosis
por: Park, Jinbong, et al.
Publicado: (2019)

The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
por: Ayodele, Olulade, et al.
Publicado: (2021)

Inhibition of human kynurenine aminotransferase isozymes by estrogen and its derivatives
por: Jayawickrama, Gayan S., et al.
Publicado: (2017)

Differential substrate recognition by isozymes of plant protein-only Ribonuclease P
por: Howard, Michael J., et al.
Publicado: (2016)

Is Transforming Growth Factor-β Signaling Activated in Human Hypertrophied Prostate Treated by 5-Alpha Reductase Inhibitor?
por: Kim, Hye Kyung, et al.
Publicado: (2013)

Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
por: Kim, Jae Heon, et al.
Publicado: (2018)

A role for MARCKS, the alpha isozyme of protein kinase C and myosin I in zymosan phagocytosis by macrophages
Publicado: (1995)

Urinary Lactate Dehydrogenase Activity and Its Isozyme Patterns in Kawasaki Disease
por: Kawamura, Yoichi, et al.
Publicado: (2017)

Studying Acetylation of Aconitase Isozymes by Genetic Code Expansion
por: Araujo, Jessica, et al.
Publicado: (2022)

Examination of differential glycoprotein preferences of N-acetylglucosaminyltransferase-IV isozymes a and b
por: Osada, Naoko, et al.
Publicado: (2022)

Steroid 5 alpha-reductase 2 enzyme variants, biomass exposure and tobacco use in Mexican patients with prostate cancer
por: Delgado-Balderas, Jesus Rolando, et al.
Publicado: (2020)

The effect of 5 alpha-reductase inhibitor therapy on prostate cancer detection in the era of multi-parametric magnetic resonance imaging
por: Kim, Jung Kwon, et al.
Publicado: (2019)

The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population
por: Choi, Se Young, et al.
Publicado: (2015)

5-Alpha-Reductase 2 Deficiency in a Woman with Primary Amenorrhea
por: Maleki, Nasrollah, et al.
Publicado: (2013)

Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
por: Escamilla-Cruz, Mariana, et al.
Publicado: (2023)

Flavonoid-Deficient Mutants in Grass Pea (Lathyrus sativus L.): Genetic Control, Linkage Relationships, and Mapping with Aconitase and S-Nitrosoglutathione Reductase Isozyme Loci
por: Talukdar, Dibyendu
Publicado: (2012)

Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia
por: Liu, Zhanliang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2uuelflvmhuilkucov1cam0aud